28 August 2023 - Geneva, Switzerland - On behalf of Stop TB Partnership's Global Drug Facility (GDF), i+solutions, the GDF-contracted procurement agent, invites all eligible suppliers to submit bids for:

ITB-Iplus/GDF-MED/2023/4, for 3HP tablets (rifapentine/isoniazid 300mg/300mg tablets) for the period until 31 December 2024.  

The purpose of the ITBs is to select a panel of suppliers who will enter into a long-term agreement with i+solutions for 3HP tablets (rifapentine/isoniazid 300mg/300mg tablets used for the once-weekly, 12 week TB preventive treatment regimen).

The ITBs are open to bidders whose products have been deemed eligible for inclusion in the tender in compliance with GDF's Quality Assurance policy and procedures. A bid submitted for a product/s for which the bidder has not received regulatory approval status in accordance with the GDF Quality Assurance policy and procedures shall not be considered for the ITB evaluation.

All bids are subject to the Instructions to Bidders and other provisions, specifications and instructions as contained in this dossier.

The ITB comprises of the following:

Bidders are requested to quote unit prices in accordance with the following delivery terms: EXW (Ex-Works), FCA (Free Carrier Alongside) and DAP India.

Failure to adhere to the requirements of the ITB may lead to disqualification of the bidder and/or rejection of the bid.

Deadline for the Request for Clarification on the ITB: 30 August 2023, 17h00 IST (India Standard Time) / 13h30 CET (Central European Time) 

Deadline for electronic submission of Technical and Financial Bids: 4 September 2023, 17h00 IST (India Standard Time) / 13h30 CET (Central European Time) 

Any bids submitted after the deadline will be rejected and not be considered during the evaluation.

Opening of the Financial Bids, accessible remotely to all Bidders, will take place on  5 September 2023 at 13h30 IST (India Standard Time) / 10h00 CET (Central European Time)